Association of the Severity of Pulmonary Valve Regurgitation on Biomarkers, Functional Capacity, and Complications in Patients with Heart Failure
Open Access
- 1 January 2025
- journal article
- Published by Sociedade Brasileira de Cardiologia in Arquivos Brasileiros de Cardiologia
- Vol. 122 (12)
Abstract
Background Pulmonary valve regurgitation (PR) is often encountered in cardiac conditions, including heart failure (HF). Although typically tolerated, severe PR can lead to right ventricular dysfunction and negative clinical outcomes; however, its specific impact within the wider HF population needs further clarification. Objectives This study was designed to evaluate the association between the severity of PR and N-terminal pro-B-type natriuretic peptide (pro-BNP) levels, its effect on functional capacity measured by the six-minute walk test (6MWT), and the incidence of significant clinical problems in patients with HF. Methods Between 2016 and 2023, we conducted a retrospective study involving 579 HF patients who underwent echocardiography at two tertiary institutions. Based on semi-quantitatively evaluated PR severity, patients were classified into four groups: No PR, Mild PR, Moderate PR, and Severe PR. Group comparisons used Chi-square tests and Kruskal-Wallis. Multivariate linear regression and Spearman correlation analyses were performed to assess associations. Results Pro-BNP levels significantly increased across PR severity groups (Median: 2,157 pg/mL [No PR] to 23,541 pg/mL [Severe PR], p<0.0001). In contrast, 6MWT distance significantly decreased with deteriorating PR severity (Median: 254 m [No PR] to 72 m [Severe PR], p<0.0001). The prevalence of orthopnea and pleural effusion also increased with PR severity. After multivariate adjustment, PR severity remained independently associated with higher pro-BNP levels (β=0.48, p=0.002) and lower 6MWT distance (β=-0.39, p=0.008). Conclusion In patients with HF, increasing severity of PR is independently associated with elevated pro-BNP levels, reduced functional capacity, and a higher burden of clinical complications.Keywords
This publication has 14 references indexed in Scilit:
- Long-Term Management of Right Ventricular Outflow Tract Dysfunction in Repaired Tetralogy of Fallot: A Scientific Statement From the American Heart AssociationCirculation, 2024
- NT‐pro‐BNP is predictive of morbidity and mortality after pulmonary thromboendarterectomy and is independent of preoperative hemodynamicsPulmonary Circulation, 2024
- Right Ventricular Function and Pulmonary Coupling in Patients With Heart Failure and Preserved Ejection FractionJACC, 2023
- The natriuretic peptide system in heart failure: Diagnostic and therapeutic implicationsPharmacology & Therapeutics, 2021
- Left Atrial Function and Maximal Exercise Capacity in Heart Failure with Preserved and Mid-Range Ejection FractionESC Heart Failure, 2020
- Outcome after surgical repair of tetralogy of Fallot: A systematic review and meta-analysisThe Journal of Thoracic and Cardiovascular Surgery, 2020
- Heart Failure Association of the European Society of Cardiology Practical Guidance on the Use of Natriuretic Peptide ConcentrationsEuropean Journal of Heart Failure, 2019
- Recommendations for Noninvasive Evaluation of Native Valvular RegurgitationJournal of the American Society of Echocardiography, 2017
- Recommendations for Cardiac Chamber Quantification by Echocardiography in Adults: An Update from the American Society of Echocardiography and the European Association of Cardiovascular ImagingEuropean Heart Journal - Cardiovascular Imaging, 2015
- Examination of the Six Minute Walk Test to Determine Functional Capacity in People with Chronic Heart Failure: A Systematic ReviewCardiopulmonary Physical Therapy Journal, 2010